Insights in Pediatric Cardiology

Post COVID MISC in PICU practical approach and mangement strategies

19^th International Conference on Pediatrics and Pediatric Cardiology
May 18-19, 2022 | Webinar

Aljalila

Children�s Speciality Hospital, Dubai, UAE

ScientificTracks Abstracts: Insights Pediatr Cardiol

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition that appears to be linked to coronavirus disease 2019 (COVID-19). Most children who become infected with the COVID-19 virus have only a mild illness. But in children who go on to develop MIS-C, some organs, and tissues — such as the heart, lungs, blood vessels, kidneys, digestive system, brain, skin, or eyes — become severely inflamed. Signs and symptoms depend on which areas of the body are affected. MIS-C is considered a syndrome — a group of signs and symptoms, not a disease — because much is unknown about it, including its cause and risk factors. Identifying and studying more children who have MIS-C may help to eventually find a cause. The CDC issued a Health Advisory on May 14, 2020, that outlines the following case definition for MIS-C.

Biography

Dr. Mohamed is a Paediatric Intensivist at Al Jalila Children’s with more than 20 years of experience in both Pediatric intensive care unit and neonatal intensive care unit. Dr Mohamed graduated from Alexandria Faculty of Medicine, Egypt one of the largest and reputable University hospital in Egypt. He completed a residency programme at Alexandria University Children’s Hospital and obtained his master’s degree in paediatrics and neonatology. Dr Mohamed also is a membership of royal colleague of pediatric and child health London UK. Dr. Mohamed was working as senior specialist in Kuwait for more than 13 years in both NICU and PICU in one of the major governmental hospital. Dr. Mohamed has an interest in PICU and management of acute bronchial Asthma, ARDS, DKA, status epilepticus and all metabolic emergencies.